Modeling <i>IKZF1</i> lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities
Jason H. Rogers(Baylor College of Medicine), Rachel E. Rau(Seattle Children's Hospital)
Cited by 10
Related Papers
Experience with ponatinib in paediatric patients with leukaemia
|British Journal of Haematology|2020|35
Clonal Competition: Cisplatin Treatment Drives Dominance of TP53- over Tet2-Mutant Stem Cell Clones
|Blood|2022|1
DNMT3A regulates murine megakaryocyte-biased hematopoietic stem cell fate decisions
|Blood Advances|2025|1